Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Raghunath

Is Gilead Sciences Stock a Buy Near 52-Week Lows for Its 4% Yield?

After trouncing the broader markets between 2004 and 2015, Gilead Sciences (GILD) has underperformed significantly in the last eight years. By the numbers, Gilead Sciences stock rose 1,550% between February 2004 and August 2015, when it traded near all-time highs. Today, the healthcare giant is down about 41% from record levels, valuing the company at a market cap of $89 billion. 

www.barchart.com
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.